Sandra Verploegen

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

Marije B. Overdijk, Sandra Verploegen, Marijn Bögels et al. · mAbs · 2015 · 503 citations · Full text

Medicine, Immunology, Oncology +17

Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange

Aran F. Labrijn, Joyce Meesters, Bart E.C.G. de Goeij et al. · Proceedings of the National Academy of Sciences · 2013 · 330 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17

A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface

Rob N. de Jong, Frank J. Beurskens, Sandra Verploegen et al. · PLoS Biology · 2016 · 226 citations · Full text

Pharmacy, Immunology, Oncology +17

Crosstalk between Human IgG Isotypes and Murine Effector Cells

Marije B. Overdijk, Sandra Verploegen, Antonio Ortiz Buijsse et al. · The Journal of Immunology · 2012 · 224 citations

Life Sciences, Immunology, Immunotherapy +12

An Antibody–Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors

Esther C.W. Breij, Bart E.C.G. de Goeij, Sandra Verploegen et al. · Cancer Research · 2013 · 221 citations · Full text

Pharmacy, Oncology, Pharmacology +17